AMBIOTIS
Desconocido
ImmunAID: Immunome project consortium for AutoInflammatory Disorders
AMBIOTIS
participó en un
H2020:
H2020-SC1-2016-2017
Systemic autoinflammatory diseases (SAID) encompass several rare disorders characterised by extensive clinical and biological inflammation....
2018-04-27 - 2024-10-31 | Financiado
2018-04-27 - 2024-10-31 | Financiado
TARKINAID: Targeting Src family tyrosine kinases in chronic autoimmune and inflammatory diseases
AMBIOTIS
participó en un
FP7:
The project aims to develop novel inhibitors of chronic autoimmune and inflammatory diseases by targeting members of the Src tyrosine kinase...
Financiado
Financiado
* No se disponen de datos de la empresa actual.